Health
Phase 1 trial results of gorilla adenovirus vaccine for COVID-19 – News-Medical.Net
A recent study published on the preprint server bioRxiv* in October 2020 reports the development of a novel vaccine based on a simian adenoviral vector obtained…
A recent study published on the preprint server bioRxiv* in October 2020 reports the development of a novel vaccine based on a simian adenoviral vector obtained from a group C gorilla isolate called GRAd32. This could help speed up vaccine development.
Low Seroprevalence for Simian Adenoviruses
Simian adenoviruses are isolated from non-human primates like the chimpanzee and gorilla and do not infect humans. Their prevalence is, therefore, low or non-existent among humans. They have been used to…
-
Noosa News17 hours agoFarmers angry as Woolworths imports US butter in green and gold packaging
-
Noosa News23 hours agoEnvironmental law reforms will fail to close ‘deforestation loopholes’ affecting Great Barrier Reef, says Ken Henry
-
General13 hours agoLiberal politicians on Qantas plane that made urgent turnaround to Adelaide
-
Noosa News15 hours agoTeen to be sentenced over stabbing of grandmother Vyleen White; Victoria follows Queensland with ‘adult time for violent crime’ laws